# Drug Resistance Mechanism of Enterobacteriaceae and Its Strategies

> **NCT05850871** · NA · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 427 (estimated)

## Conditions studied

- Carbapenem-Resistant Enterobacteriaceae Infection

## Interventions

- **DRUG:** CAZ/AVI plus Aztreonam
- **OTHER:** Conventional treatment

## Key facts

- **NCT ID:** NCT05850871
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-06
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 427 (ESTIMATED)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05850871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05850871, "Drug Resistance Mechanism of Enterobacteriaceae and Its Strategies". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05850871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*